Michał Dunikowski
Associate
Tax Advisor
Michał handles matters in the fields of capital markets law and corporate law. He participates in projects related to raising equity and debt financing in connection with issuance of financial instruments in public and private transactions.
Languages:
BIO
Michał participates in work related to issues of securities via public and private offerings, including bonds. He is involved in projects related to the admission and introduction of financial instruments to trading on the regulated market. He represents clients before the Polish Financial Supervision Authority, the National Depository for Securities and the Warsaw Stock Exchange. Provides day-to-day services to public companies in the field of corporate law, fulfilment of disclosure obligations, and implementation of incentive programs. Advises on performance of notification obligations by shareholders and investors in connection with acquisition and purchase of significant blocks of shares. Participates in mergers and acquisitions of public companies, also works on due diligence studies preceding equity transactions. He provides services to other capital market participants. In addition, he is qualified as a tax advisor.
Prior to joining GESSEL, he worked with a number of law firms, dealing with issues in mergers and acquisitions, intra-group reorganizations, capital markets law, and tax law.
Experience
Selected projects
- Advised Bioceltix S.A. on changing its listing market from NewConnect to the main floor of the Warsaw Stock Exchange
- Advised DataWalk S.A. on its public offering of P-series new issue shares
- Advised Kredyt Inkaso S.A. on the establishment of its bond issue program
- Advised Vercom S.A. on a cross-border merger process
News
& Insights
16.10.2023
We advised the WSE-listed company Creotech Instruments S.A.
We advised the WSE-listed company Creotech Instruments S.A. on a non-brokered public offering conducted under an accelerated bookbuilding procedure worth approximately P...
05.07.2023
We advised WSE-listed Bioceltix S.A. on a non-brokered public offering of the Company’s shares
We advised WSE-listed Bioceltix S.A. on a non-brokered public offering of the Company's shares carried out under the accelerated book-building (ABB) procedure and a rela...
26.06.2023
We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction
We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd. The transaction was executed ...
23.06.2023
We advised WSE-listed Genomtec S.A. on a non-brokered public offering
We advised WSE-listed Genomtec S.A. on a non-brokered public offering of the company's shares carried out under an accelerated bookbuilding procedure (ABB) and a related...
Education and achievements
- Legal studies at the Faculty of Law and Administration of Jagiellonian University (2020); attorney’s training articles (2021)
- National Chamber of Tax Advisors (2022)
- Completed courses – Center for American Law at the Faculty of Law and Administration of the University of Warsaw